Reply to “Does multiple intrahepatic cholangiocarcinoma worsen prognosis as “M1” stage?”; multiple primaries vs liver metastases

Angela Lamarca; Alvaro Santos‐laso; Kirsten Utpatel; Adelaida La Casta; Simone Stock; Alejandro Forner; Jorge Adeva; Trine Folseraas; Luca Fabris; Rocio Ir Macias; Marcin Krawczyk; Marek Krawczyk; Vincenzo Cardinale; Chiara Braconi; Domenico Alvaro; Matthias Evert; Jesus M. Banales; Juan W Valle

doi:10.1002/hep.31740

Reply to “Does multiple intrahepatic cholangiocarcinoma worsen prognosis as “M1” stage?”; multiple primaries vs liver metastases

Angela Lamarca, Alvaro Santos‐laso, Kirsten Utpatel, Adelaida La Casta, Simone Stock, Alejandro Forner, Jorge Adeva, Trine Folseraas, Luca Fabris, Rocio Ir Macias, Marcin Krawczyk, Marek Krawczyk, Vincenzo Cardinale, Chiara Braconi, Domenico Alvaro, Matthias Evert, Jesus M. Banales, Juan W Valle

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Letter › peer-review

14 Downloads (Pure)

Abstract

We thank Zhang and colleagues for their Letter to the Editor (1) regarding our work (2). Our manuscript (“Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System”(2)), suggested changes to the American Joint Committee on Cancer (AJCC) staging classification for intrahepatic cholangiocarcinoma (iCCA), by classifying “liver metastases” as stage IV rather than stage II/III in the absence/presence of lymph node metastases, respectively, as per AJCC v.8 (3).

Original language	English
Journal	Hepatology
Early online date	7 Feb 2021
DOIs	https://doi.org/10.1002/hep.31740
Publication status	E-pub ahead of print - 7 Feb 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/hep.31740Licence: Other

hepatology reply letter ENSCCA T2M1 FINALv.3Accepted author manuscript, 21.7 KB

https://onlinelibrary.wiley.com/doi/10.1002/hep.31740

Cite this

Lamarca, A., Santos‐laso, A., Utpatel, K., La Casta, A., Stock, S., Forner, A., Adeva, J., Folseraas, T., Fabris, L., Macias, R. I., Krawczyk, M., Krawczyk, M., Cardinale, V., Braconi, C., Alvaro, D., Evert, M., Banales, J. M., & Valle, J. W. (2021). Reply to “Does multiple intrahepatic cholangiocarcinoma worsen prognosis as “M1” stage?”; multiple primaries vs liver metastases. Hepatology. Advance online publication. https://doi.org/10.1002/hep.31740

@article{d02d74250d724822856a8f7f8f3e5ec2,

title = "Reply to “Does multiple intrahepatic cholangiocarcinoma worsen prognosis as “M1” stage?”; multiple primaries vs liver metastases",

abstract = "We thank Zhang and colleagues for their Letter to the Editor (1) regarding our work (2). Our manuscript (“Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System”(2)), suggested changes to the American Joint Committee on Cancer (AJCC) staging classification for intrahepatic cholangiocarcinoma (iCCA), by classifying “liver metastases” as stage IV rather than stage II/III in the absence/presence of lymph node metastases, respectively, as per AJCC v.8 (3).",

author = "Angela Lamarca and Alvaro Santos‐laso and Kirsten Utpatel and {La Casta}, Adelaida and Simone Stock and Alejandro Forner and Jorge Adeva and Trine Folseraas and Luca Fabris and Macias, {Rocio Ir} and Marcin Krawczyk and Marek Krawczyk and Vincenzo Cardinale and Chiara Braconi and Domenico Alvaro and Matthias Evert and Banales, {Jesus M.} and Valle, {Juan W}",

year = "2021",

month = feb,

day = "7",

doi = "10.1002/hep.31740",

language = "English",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams & Wilkins",

}

Lamarca, A, Santos‐laso, A, Utpatel, K, La Casta, A, Stock, S, Forner, A, Adeva, J, Folseraas, T, Fabris, L, Macias, RI, Krawczyk, M, Krawczyk, M, Cardinale, V, Braconi, C, Alvaro, D, Evert, M, Banales, JM & Valle, JW 2021, 'Reply to “Does multiple intrahepatic cholangiocarcinoma worsen prognosis as “M1” stage?”; multiple primaries vs liver metastases', Hepatology. https://doi.org/10.1002/hep.31740

TY - JOUR

T1 - Reply to “Does multiple intrahepatic cholangiocarcinoma worsen prognosis as “M1” stage?”; multiple primaries vs liver metastases

AU - Lamarca, Angela

AU - Santos‐laso, Alvaro

AU - Utpatel, Kirsten

AU - La Casta, Adelaida

AU - Stock, Simone

AU - Forner, Alejandro

AU - Adeva, Jorge

AU - Folseraas, Trine

AU - Fabris, Luca

AU - Macias, Rocio Ir

AU - Krawczyk, Marcin

AU - Krawczyk, Marek

AU - Cardinale, Vincenzo

AU - Braconi, Chiara

AU - Alvaro, Domenico

AU - Evert, Matthias

AU - Banales, Jesus M.

AU - Valle, Juan W

PY - 2021/2/7

Y1 - 2021/2/7

N2 - We thank Zhang and colleagues for their Letter to the Editor (1) regarding our work (2). Our manuscript (“Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System”(2)), suggested changes to the American Joint Committee on Cancer (AJCC) staging classification for intrahepatic cholangiocarcinoma (iCCA), by classifying “liver metastases” as stage IV rather than stage II/III in the absence/presence of lymph node metastases, respectively, as per AJCC v.8 (3).

AB - We thank Zhang and colleagues for their Letter to the Editor (1) regarding our work (2). Our manuscript (“Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System”(2)), suggested changes to the American Joint Committee on Cancer (AJCC) staging classification for intrahepatic cholangiocarcinoma (iCCA), by classifying “liver metastases” as stage IV rather than stage II/III in the absence/presence of lymph node metastases, respectively, as per AJCC v.8 (3).

U2 - 10.1002/hep.31740

DO - 10.1002/hep.31740

M3 - Letter

SN - 0270-9139

JO - Hepatology

JF - Hepatology

ER -

Reply to “Does multiple intrahepatic cholangiocarcinoma worsen prognosis as “M1” stage?”; multiple primaries vs liver metastases

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this